Lanirapid


Combined with:

Aspirin
Lasix
Warfarin Sodium

Indications and Reactions:

Role Indications Reactions
Secondary
Cardiac Failure 21.8%
Atrial Fibrillation 15.5%
Hypertension 7.7%
Diabetes Mellitus 7.0%
Insomnia 5.6%
Cardiac Failure Chronic 4.9%
Thrombosis Prophylaxis 4.9%
Conjunctivitis Allergic 4.2%
Infection 4.2%
Asthma 3.5%
Constipation 2.8%
Hyperuricaemia 2.8%
Back Pain 2.1%
Depression 2.1%
Gastritis Prophylaxis 2.1%
Intercostal Neuralgia 2.1%
Thyroiditis Chronic 2.1%
Angina Pectoris 1.4%
Coronary Arterial Stent Insertion 1.4%
Delirium 1.4%
Cerebral Infarction 9.4%
Syncope 9.4%
Therapeutic Agent Toxicity 9.4%
White Blood Cell Count Decreased 9.4%
Lung Disorder 6.3%
Oedema 6.3%
Overdose 6.3%
Urticaria 6.3%
Altered State Of Consciousness 3.1%
Anaemia 3.1%
Arrhythmia 3.1%
Cardiac Arrest 3.1%
Cardio-respiratory Arrest 3.1%
Decreased Appetite 3.1%
Dermatitis Exfoliative 3.1%
Dyspnoea 3.1%
Feeling Abnormal 3.1%
Gastrooesophageal Reflux Disease 3.1%
Heart Rate Decreased 3.1%
Hiatus Hernia 3.1%
Concomitant
Hypertension 15.6%
Atrial Fibrillation 13.4%
Product Used For Unknown Indication 9.4%
Cardiac Failure 9.2%
Cardiac Failure Chronic 8.3%
Drug Use For Unknown Indication 7.3%
Prophylaxis 5.6%
Diabetes Mellitus 5.1%
Gastritis 3.0%
Insomnia 2.8%
Constipation 2.7%
Arrhythmia 2.4%
Rheumatoid Arthritis 2.4%
Hepatitis C 2.2%
Angina Pectoris 2.1%
Cardiac Failure Congestive 1.8%
Gastric Ulcer 1.8%
Cerebral Infarction 1.8%
Hyperlipidaemia 1.7%
Hyperuricaemia 1.6%
Cardiac Failure 9.9%
Pneumonia 7.3%
Anaemia 6.9%
Interstitial Lung Disease 6.0%
Renal Failure 6.0%
Pyrexia 5.6%
Rhabdomyolysis 5.2%
Thrombocytopenia 5.2%
Cerebral Infarction 4.7%
Respiratory Failure 4.7%
Ventricular Tachycardia 4.7%
White Blood Cell Count Decreased 4.7%
Loss Of Consciousness 4.3%
Renal Failure Acute 3.9%
Toxic Epidermal Necrolysis 3.9%
Cardiac Failure Congestive 3.4%
Pancytopenia 3.4%
Renal Impairment 3.4%
Shock 3.4%
Vomiting 3.4%

Drug Data